These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1555659)

  • 21. Piperidine-renin inhibitors compounds with improved physicochemical properties.
    Güller R; Binggeli A; Breu V; Bur D; Fischli W; Hirth G; Jenny C; Kansy M; Montavon F; Müller M; Oefner C; Stadler H; Vieira E; Wilhelm M; Wostl W; Märki HP
    Bioorg Med Chem Lett; 1999 May; 9(10):1403-8. PubMed ID: 10360745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin inhibitors. I. Synthesis and structure-activity relationships of transition-state inhibitors containing homostatine analogues at the scissile bond.
    Atsuumi S; Nakano M; Koike Y; Tanaka S; Matsuyama K; Nakano M; Morishima H
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):364-70. PubMed ID: 1606632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
    Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
    Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The discovery and synthesis of potent zwitterionic inhibitors of renin.
    Aspiotis R; Chen A; Cauchon E; Dubé D; Falgueyret JP; Gagné S; Gallant M; Grimm EL; Houle R; Juteau H; Lacombe P; Laliberté S; Lévesque JF; MacDonald D; McKay D; Percival MD; Roy P; Soisson SM; Wu T
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2430-6. PubMed ID: 21429746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases.
    Politi A; Durdagi S; Moutevelis-Minakakis P; Kokotos G; Papadopoulos MG; Mavromoustakos T
    Eur J Med Chem; 2009 Sep; 44(9):3703-11. PubMed ID: 19410337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size of the aliphatic chain of sodium houttuyfonate analogs determines their affinity for renin and angiotensin I converting enzyme.
    Yuan L; Wu J; Aluko RE
    Int J Biol Macromol; 2007 Aug; 41(3):274-80. PubMed ID: 17467790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors.
    Imaeda Y; Tawada M; Suzuki S; Tomimoto M; Kondo M; Tarui N; Sanada T; Kanagawa R; Snell G; Behnke CA; Kubo K; Kuroita T
    Bioorg Med Chem; 2016 Nov; 24(22):5771-5780. PubMed ID: 27687967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
    Chen A; Bayly C; Bezençon O; Richard-Bildstein S; Dubé D; Dubé L; Gagné S; Gallant M; Gaudreault M; Grimm E; Houle R; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; Martin D; McKay D; Powell D; Remen L; Soisson S; Toulmond S
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2204-9. PubMed ID: 20206513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3,4-Diarylpiperidines as potent renin inhibitors.
    Lacombe P; Arbour M; Aspiotis R; Cauchon E; Chen A; Dubé D; Falgueyret JP; Fournier PA; Gallant M; Grimm E; Han Y; Juteau H; Liu S; Mellon C; Ramtohul Y; Simard D; St-Jacques R; Tsui GC
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1953-7. PubMed ID: 22325946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equipotent activity in both enantiomers of a series of ketopiperazine-based renin inhibitors.
    Powell NA; Clay EH; Holsworth DD; Bryant JW; Ryan MJ; Jalaie M; Zhang E; Edmunds JJ
    Bioorg Med Chem Lett; 2005 May; 15(9):2371-4. PubMed ID: 15837327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
    Bode W; Turk D; Stürzebecher J
    Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin inhibitors: a search for principles of design.
    Haber E; Hui KY; Carlson WD; Bernatowicz MS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S54-8. PubMed ID: 2485064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular modeling of renin inhibitor P2 substituents.
    Lunney EA; Humblet CC; Repine JT; Blundell TL; Cooper JB; Sibanda BL
    Adv Exp Med Biol; 1991; 306():391-4. PubMed ID: 1812735
    [No Abstract]   [Full Text] [Related]  

  • 34. Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors.
    Scheiper B; Matter H; Steinhagen H; Stilz U; Böcskei Z; Fleury V; McCort G
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6268-72. PubMed ID: 20850300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure--activity relations of antagonists of the renin--angiotensin system.
    Marshall GR
    Fed Proc; 1976 Nov; 35(13):2494-501. PubMed ID: 185094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin inhibitors: C-terminal oxetanes as potent transition-state mimics.
    Rosenberg SH; Spina KP; Stein H; Cohen J; Baker WR; Kleinert HD
    Bioorg Med Chem; 1994 Sep; 2(9):927-37. PubMed ID: 7712128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New renin inhibitor VTP-27999 alters renin immunoreactivity and does not unfold prorenin.
    Krop M; Lu X; Verdonk K; Schalekamp MA; van Gool JM; McKeever BM; Gregg R; Danser AH
    Hypertension; 2013 May; 61(5):1075-82. PubMed ID: 23460288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new class of orally active glycol renin inhibitors containing phenyllactic acid at P3.
    Hanson GJ; Baran JS; Lowrie HS; Russell MA; Sarussi SJ; Williams K; Babler M; Bittner SE; Papaioannou SE; Yang PC
    Biochem Biophys Res Commun; 1989 Apr; 160(1):1-5. PubMed ID: 2496685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors.
    Powell NA; Ciske FL; Cai C; Holsworth DD; Mennen K; Van Huis CA; Jalaie M; Day J; Mastronardi M; McConnell P; Mochalkin I; Zhang E; Ryan MJ; Bryant J; Collard W; Ferreira S; Gu C; Collins R; Edmunds JJ
    Bioorg Med Chem; 2007 Sep; 15(17):5912-49. PubMed ID: 17574423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors.
    Grice CA; Tays K; Khatuya H; Gustin DJ; Butler CR; Wei J; Sehon CA; Sun S; Gu Y; Jiang W; Thurmond RL; Karlsson L; Edwards JP
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2209-12. PubMed ID: 16458510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.